Rick J Carlson
Rick J Carlson
The Food and Drug Administration (FDA) approval of BiDil unleashed a vigorous commentary, mostly critical of the decision. The FDA was soon caught between biologists, who see research and clinical utility in using racial classifications, an...
Pamela Sankar,Jonathan Kahn
Pamela Sankar
Recent Food and Drug Administration (FDA) approval of the first drug with a race-specific indication has fueled the controversy over the meaning of race and ethnicity and raised questions over whether this move should be seen as an advance ...
Medicare extra: a comprehensive benefit option for Medicare beneficiaries [0.03%]
加强型医疗保险： Medicare参保人的全面补充保险方案
Karen Davis,Marilyn Moon,Barbara Cooper et al.
Karen Davis et al.
The proposed Part E, Medicare Extra, outlined in this paper adds a comprehensive benefit option to Medicare, eliminating the need for beneficiaries to purchase a private drug plan and Medigap supplemental coverage. Financed by a budget-neut...
Health care costs in old age are related to overweight and obesity earlier in life [0.03%]
中年期超重和肥胖与老年医疗费用相关
Martha L Daviglus
Martha L Daviglus
Obesity is responsible for at least 90 billion dollars in direct U.S. health care costs annually. A high proportion of people who were overweight or obese at younger ages survives past age sixty-five to experience adverse consequences. The ...
Scott Ramsey
Scott Ramsey
U.S. spending for cancer is increasing rapidly, because of the aging society, greater use of screening services, and new treatments that come with very high price tags. In this Perspective I argue that projections of the impact of medical i...
Bruce C Viadeck
Bruce C Viadeck
The relationship between the health of an insured population and the costs of insuring them is a lot more complicated than might first appear. The excellent paper by Geoffrey Joyce and colleagues helps explain why. The obvious interaction b...
Donna I Regenstreif
Donna I Regenstreif
As this collection of papers shows, Medicare faces serious future challenges as the population it serves grows larger and older in the coming decades. Variation in the way health care is provided--also known as process variability--is a maj...
S Jay Olshansky
S Jay Olshansky
Is the health of the U.S. population improving or getting worse, and how are health and medical costs influenced by obesity? How will anticipated advances in the biomedical sciences influence life expectancy and the cost of health care? The...
James Lubitz
James Lubitz
The RAND Future Elderly Model illustrates important principles about the relation among medical technologies, health spending, and health. New technologies add to spending because the costs of the new technologies and the health care costs ...
David M Cutler
David M Cutler
The papers in this special Health Affairs collection offer a fresh and very important look at Medicare's future. Taken as a whole, they suggest that financing problems in Medicare will be particularly acute in coming decades. Other pieces o...